ArticleACS infectious diseases2024

In Vivo Activity Profiling of Biosynthetic Darobactin D22 against Critical Gram-Negative Pathogens.

Andreas M Kany et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.